Local Non-pituitary Growth Hormone Is Induced With Aging And Facilitates Epithelial Damage
Jul 13, 2022
Please contact oscar.xiao@wecistanche.com for more information
SUMMARY
Microenvironmental factors modulating age-related DINA damage are unclear. Non-pituitary growth hormone (np) is induced in the human colon, non-transformed human colon cells, and fibroblasts, and in 3-dimensional intestinal organoids with age-associated DNA damage. Autocrine/paracrine npGH suppresses p53 and attenuates DNA damage response(DDR) by inducingTRIM29 and reducing ATM phosphorylation, leading to reduced DNA repair and DNA damage accumulation. Organoids cultured up to 4 months exhibit aging markers, p16, and SA-β-galactosidase and decreased telomere length, as well as DNA damage accumulation, with increased npGH, suppressed p53, and attenuated DDR. Suppressing GH in aged organoids increases p53 and decreases DNA damage. WT mice exhibit age-dependent colon DNA damage accumulation, while in aged mice devoid of colon GH signaling, DNA damage remains low, with elevated p53. As age-associated npGH induction enables a pro-proliferative microenvironment, abrogating npGH signaling could be targeted as anti-aging therapy by impeding DNA damage and age-related pathologies.
INTRODUCTION
Biological functions decline with aging concomitantly with increased age-related disease. flavonoids Age-related pathologies are driven by accumulated DNA damage and deficiencies in DNA repair that cause mutations and age-associated chromosomal aberrations. Persistent DNA damage may also block cell proliferation, resulting in senescence and apoptosis, thereby further driving the aging process (Ou and Schumacher, 2018). DNA damage accumulates with age in wild-type (WT), non-transformed human and murine cells, as evidenced by increased phosphorylated histone 2A variant (yH2AX), a marker of double-strand DNA breaks (DSBs) (Sedelnikova et al., 2004) and unrepaired DNA damage(Dolle et al.,1997; Hasty et al.,2003; Lombard et al., 2005; Petr et al., 2020). Genomic instability resulting from defective DNA damage repair may favor cellular transformation (Negrini et al., 2010). DNA damage triggers the phosphorylation of ataxia-telangiectasia-mutated (ATM) genes, responsible for the repair of single-strand DNA breaks and DSBs. ATM phosphorylates and stabilizes tumor suppressor p53, thus ensuring DNA damage repair by facilitating several DNA repair pathways. Thus, ATM plays a key role in activating both the DNA damage response (DDR) and DNA repair(Ou and Schumacher,2018).

Please click here to know more
ATM expression and activity deteriorate with age (Feng et al.。2007; Gutierrez-Martinez et al.,2018), likely resulting in age-related functional p53 loss and leading to accumulated DNA damage and chromosomal instability (Simon et al,2009).p53 responses to stressors such as radiation are lower in older mice(Feng et al.,2007) and in human dermal fibroblasts derived from aged individuals (Goukassian et al.,2000). Thus, the hallmarks of aging include decreased DDR activity and p53 suppression with accumulated unrepaired DNA damage, all enabling a favorable milieu for epithelial proliferation(Lopez-Otin et al.,2013).
As pituitary growth hormone (GH) secretion declines with age, altered GH signaling has been implicated in the aging process (Ho and Hoffman,1993) Nevertheless, a body of evidence supports the beneficial effects of GH attenuation on aging.In the cell, murine, and human disease models (Brown-Borg et al.,1996; Junnila et al.,2013), the benefits of GH deficiency stem primarily from observations favoring secondary factors that extend life-span, including enhanced insulin sensitivity, decreased hepatic protein oxidation, decreased cancer incidence, and decreased age-associated inflammation (Aguiar-Oliveira and Bartke,2019; Bartke,2016; Junnila et al.,2013; Spadaro et al.,2016).Offspring of Leiden study families with familial longevity and lower mortality than environmentally matched controls have lower integrated circulating GH levels (van der Spoeletal.,2016), while GHexcess decreases lifespan as seen in patients with acromegaly (Chesno-kova et al.,2019a; Melmed,2020; Waters and Barclay,2007) and in transgenic murine models overexpressing GH(Bartke, 2003). hesperidin uses Some have suggested a negative correlation between height and longevity in humans(He et al.,2014; Samaras and Storms, 1992) and in dogs (Greer et al.,2007), We hypothesized that adverse GH effects on aging may, at least in part, be attributed to accumulated DNA damage(Ches-nokova and Melmed,2020). In support of this premise, lymphocytes derived from acromegaly patients exhibit DNA damage with increased chromosomal aberrations (Bayram et al,2014), while unrepaired DNA damage accumulates in the liver of a zebrafish acromegaly model (Elbialy et al.,2018). High circulating GH levels attenuate murine colon DNA repair, triggering DNA damage accumulation, while DNA damage is attenuated after blocking GH receptor(GHR) in human colon cells and in mice with abrogated GHR signaling (Chesnokova et al.,2019a).
Non-pituitary GH (np) synthesized locally in peripheral tissues is identical to endocrine GH1 produced by the pituitary and acts through autocrine/paracrine mechanisms via the widely expressed GHR(Ballesteros et al.,2000)that recognizes both pituitary GH and npGH ligands (Waters and Barclay,2007; Waters et al,2006). lost empire cistanche As DDR activation induces npGH(Chesnokova et al.,2013), we hypothesized that age-associated accumulated colon DNA damage induces npGH expression, which, in turn, would further constrain DNA damage repair.

Cistanche can anti-aging
Using both in vitro and ex vivo human models reflective of ag-ing, we show here that npGH is induced and DNA damage accumulates in aged human tissues, as evidenced by increased H2AX phosphorylation (yH2AX). Furthermore, colon DNA damage is significantly increased in aged WT mice, while epithelial DNA damage remains low in age-matched GHR--mice devoid of GH signaling and in colon-specific GHR knockout mice (GHRcolKO).
Local npGH was also induced in aged 3-dimensional (3D) in-testinal organoids generated from induced human pluripotent stem cells (iPSCs)(Barrett et al,2014; Chesnokova et al, 2019a). Organoid npGH, in turn, suppressed p53 and attenuated DNA damage repair. micronized purified flavonoid fraction 1000 mg uses Effects ofnpGH were likely paracrine, as co-culturing GH-expressing fibroblasts with Colon Intestine-Chip microfluidic devices embedded with human colonoidsled to sup-pressed p53/p21 and enhanced DNA damage. By contrast, suppressing GH in aged organoids prevented DNA damage.
Thus, we show that epithelial npGH is strongly induced during aging and that npGH reduces DNA repair and facilitates age-associated DNA damage accumulation. Overall, the results suggest that local colon epithelial npGH triggers a mucosal field change, creating a milieu of chromosomal instability that is favor-able for neoplastic development in aging tissue.
Importantly, although there is a widespread inappropriate use of GH as an"anti-aging" hormone despite the lack of compelling impact on the aging process (Blackman et al.,2002; Clemmons et al..2014; Lieut al.,2007; Melmed,2019), our results show that local GH signaling contributes to the tissue microenvironment, favoring the development of age-related pathologies. Suppressing local npGH signaling to constrain adverse epithelial DNA damage may therefore offer an anovulant-aging therapeutic target. Results of these studies inform an innovative approach to lifespan extension (i.e., suppression rather than induction of local GH signaling). RESULTS
Human colon DNA damage and npGH accumulate with aging
Age-associated DNA damage was assessed in non-tumorous human colon paraffin tissue samples derived from patient cohorts spanning 3 age groups: young(18-39 years), middle-aged (40-60 years), and aged (61-88 years). When scored for yH2AX, 3 of 11 samples (27%) in the young cohort exhibited DNA damage, 8 of 16(50%)exhibited DNA damage in middle age, and 8 of 18(45%) aged samples exhibited DNA damage (Figures 1A-1C and 1J).
As we previously showed that DNA damage induces npGH (Chesnokova et al, 2013), we sought to determine whether the age-dependent accumulation of DNA damage was associated with GH expression in non-tumorous colon tissue. As no is expressed in neuroendocrine colon cells(Chesnokova et al, 2016), we excluded these cells from analysis.

Epithelial GH expression was detected in 16%-17% of normal colon samples derived from middle-aged and aged cohorts (38 and 42 samples, respectively) but in only 2% of the young cohort (37 samples), while the GH expression score was increased in the middle-aged cohort and further increased in the aged cohort samples (p<0.01) (Figures 1D-1F and 1K). Furthermore, colon mRNA GH expression increased in both middle-aged (30% of 10 samples) and aged (26% of 14 samples) versus young cohort samples(17% of9 samples)(p<0.01 and p<0.05, respectively)(Figures 1G-1). oteflavonoid In summary, these results point to DNA damage accumulation with no induction in the aging colon.
DDR activation induces local npGHin murine and human colon
We next considered whether activated DDR triggers local colon npGH expression and treated mice with nutlin3 to stabilize p53 (Vassilev et al,2004)and observed induced colon p53 and up(Figure 2A).In addition, in colon adenocarcinoma specimens derived from the same patients before and after DNA damaging therapies (Table S1), we observed modest pre-treatment baseline epithelial npGH expression and increased npGH expression after therapy in all 6 patient samples studied (p<0.01) (Figure 2B). Enhanced GH expression was also observed in tumor-associated fibroblasts after DNA damage(Figure 2C), indicating that these findings are likely not cell-specific.
DDR activates GH expression in vitro
We used the topoisomerase Il inhibitor etoposide to produce both single-strand DNA breaks and DSBs (Walles et al,1996)and to determine whether DDR activates GH in vitro. The DNA damage-induced npGH in NCC,hNCF, and HCT116human colon adenocarcinoma cells(Figures 3A and S1A-S1C); in organo-ids, etoposide-induced GH and GH mRNA(Figures 3B and S1D), while IGF1 and prolactin mRNA levels were unchanged (Figure S1E). STAT5 phosphorylation, a downstream GH signal (Waters, 2016), was induced in all cell types (Figures 3A-3C and S1A-S1C). By contrast, abrogating npGH with GH small interfering RNA (siRNA) prevented etoposide from inducing pSTAT5(Fig-ures 3C and S1F), providing evidence that DNA damage-induced colon npGH is functionally active. Imaging of NCC treated with etoposide for 24 h showed GH and yH2AX co-expression in multiple cells (Figure 3D).
Epithelial cells undergoing DNA damage secrete GH To determine whether induced intracellular npGH exerts autocrine/paracrine effects, we assessed GH levels secreted into NCC and organoid culture medium after etoposide treatment. Medium collected from ANCC at 8 and 24 h after treatment and from organoids at 4-48 h after treatment showed time-dependent GH increases after DDR activation (Figure 3E). Because NCC and organoids express GH receptors as does human colon tissue(Chesnokova et al.,2016), these results suggest that local GH induced in response to DNA damage may subject aging tissue to autocrine/paracrine actions.
Autocrine/paracrine GH suppresses human colon cell p53
As endocrine GH suppresses murine colon p53(Chesnokova et al,2016), we determined whether local GH exerts similar au-autocrine/paracrine effects in human epithelial colon cells. Analysis of two separate NCC lines derived from two different patients after nucleofection with hGH or infection with lentivirus express-ing GH (lenti-GH) (Figures 4A, 4B, and S2) as well as organoids stably expressing hGH(Figure 4C) showed suppressed p53 and concomitant overexpression. Cells derived from organo-ids infected with lenti-GH or empty vector (lenti-V) pulsed with bromodeoxyuridine (BrdU)showed p53 suppression followed by modest but significantly increased BrdU incorporation as-sessed by fluorescence-activated cell sorting (FACS)(Figure S3A). By contrast, GH suppression with lentivirus expressing small hairpin GH (GH) led to decreased colony formation and colony size in NCC (Figures S3B and S3C), indicating pro-pro-literature npGH actions.
Paracrine GH effects in human Colon Intestine-Chip To assess the paracrine effects of npGH on intestinal mucosal epithelial cells, we co-cultured UNCF infected with lenti-GH and Colon Intestine-Chip microfluidic devices(Kasendra et al, 2020) seeded with healthy colonic organoid-derived epithelial cells for 8 days. Local GH secretion from hNCF into the medium was confirmed by ELISA(338ng/mL/1×10°cells).5-Ethynyl-2'-deoxyuridine (EdU) (20 μM) was added on day 7, chips were fixed 24 h later, and stained for EdU,andγH2AX, and EdU+nuclei were counted in epithelial cells. A separate set of chips seeded

with epithelial cells was used to assess p53/p21 by western blot. The proliferation of chip epithelial cells increased (p<0.05), likely due to decreased p53 and p21 (Figures 4D and 4E). Moreover, DNA damage accumulation was evident, with increased numbers of cells expressing γH2AX (p <0.01) (Figure 4F).
Autocrine/paracrine GH suppresses DDR
Activation of ATM upon DNA damage phosphorylates H2AX, which marks damaged DNA sites to activate DDR and promote repair (Turinetto and Giachino,2015).ATM also phosphorylates p53, further enhancing DNA repair (Blackford and Jackson 2017). In hNCC as well as in organoids infected either with pIRES2-ZsGreen1hGH or with lentil-GH, GH overexpression suppressed the phosphorylation of ATM and DNA-protein kinase (PK)cs, both involved in DNA repair (Blackford and Jackson. 2017), and decreased phosphorylation of a target protein p53 (Figures 5A-5C).

Tip60 histone acetylase activates ATM(Jackson and Bartek, 2009) and is negatively regulated by TRIM29 (Sho et al.,2011; Sun et al,2005). We observed that GH overexpression in NCC and in organoids also resulted in TRIM29 induction, which in turn suppressed Tip60 (Figures 5A-5C). Similar results were observed in the second NCC line 48 h after nucleofection with a plasmid expressing GH and at 6 days after infection with lenti-GH (Figures S4A and S4B).
Autocrine/paracrine GH attenuates DNA repair
We next measured effects on DSB repair mechanisms, specifically error-prone non-homologous end joining (NHEJ)(Jackson and Bartek, 2009) and error-proof homologous recombination (HR)(Beucher et al.,2009; Blackford and Jackson,2017; Chapman et al.,2012). We nucleofected NCC stably expressing NHEJ and HR reporter cassettes with pcDNA3.1-human GH1 (hGH1) plasmids, induced DSBs by co-transfecting with a plasmid encoding I-Excel endonuclease, and measured the rejoining of DSB repair reporters. Transfection efficiency was controlled by co-transfecting with plasmid encoding DsRed (Seluanov et al, 2010). NHEJ efficiency after pcDNA3.1-hGH1 nucleofection was 0.77-0.83and reduced at 48h(p<0.05)(Figure5D), and HR,while low(0.05), consistent with other reports (Chitnis et al,2014;Gatei et al.,2011),showed consistently decreased efficiency by up to 38.7%±3.5% (n=4 independent experiments,p<0.05) at 72 h.
Autocrine/paracrine GH increases unrepaired DNA damage
Examining whether npGH increases DNA damage, we observed that NCC and organoids stably transfected with lenti-GH showed increased endogenous unrepaired DNA damage as measured by Comet assay (p< 0.05) (Lee and Paull, 2007)(Figures 5E and 5F). Levels of unrepaired DNA were also markedly increased in a second NCC line in cells nucleofected with a plasmid expressing GH or infected with lenti-GH (Figures S4C and S4D). Overall, these results show that npGH is induced in response to DNA damage and enhances DNA damage accumulation by interfering with both DDR and DNA repair pathways.
GH is induced in aged 3D human intestinal organoids and attenuates DDR
Following the observed increased GH expression and DNA damage in aged human colon specimens, we"aged"organo-ids generated from three independent iPSC lines to recapitulate a model of aging human tissue. These organoids are composed of enterocytes, goblet cells, Paneth cells, and enteroendocrine cells and express caudal-type homeobox 2(CDX2)(Barrett et al..2014; Gao et al.,2009; Workman et al.,2017). Two of three iPSC lines (lines 1 and 3) were obtained from individuals older than age 60 years old, and the third iPSC line (line 2) was derived from fibroblasts of a 30-year-old individual. Organoids generated from lines 1 and 3 were cultured for up to 2 months, at which point cell proliferation slowed significantly. By contrast, organoids generated from line 2 proliferated robustly in culture for up to 4 months. Cellular aging was confirmed in all 3 lines by increased p16, as well as by decreased telomere length (p<0.05)(Figures 6A and 6B). In aged organoids, we also found increased senescence-associated β-galactosidase (SA-β-galactosidase) activity, which has been shown to increase with age (Kurz et al., 2000; Lee et al., 2006), as well as increased β-galactosidase protein expression, which correlates with SA-β-galactosidase enzymatic activity(Figures 6A and S5A).
As these in vitro organoid features appear to faithfully recapitulate cellular changes consistent with aging human tissue (Baker et al.,2011;Lieut al.,2019; Lopez-Otin et al.,2013), we used this model to further study signaling mechanisms underlying human colon epithelial aging. In line 1, GH mRNA levels were induced after 1 month in culture and further increased after 2 months (p < 0.05)(Figure 6C), which is consistent with significantly increased npGH seen in aged organoids on both western blot and immunohistochemistry(IHC)(Figures 6D, 6E, and S5B). yH2AX was also strongly induced with prolonged culture, indicating accumulated endogenous DNA damage with in vitro ag-ing. Consistent with results showing suppressed p53 in NCC and organoids transfected with GH (Figures 4A-4C), we observed suppressed p53 at 1 and 2 months of culture, concordant with increased npGH (Figures 6E and S5B).Similar results (A and B) Western blot of (A) ANCC,hNCF, and HCT116 cells and (B) organoids. Cells were treated with indicated doses of etoposide and analyzed 24 h later. Organoids were treated with 3 uM etoposide (Etop).
(C) NCC nucleofected with GH siRNA (siGH RNA) or scramble RNA (Scr RNA)as a control for 24 h was treated with indicated doses of etoposide (Etop) and analyzed 24 h later. ImageJ quantification of western blots is depicted in Figure S1.
(D) Representative image of NCC treated with 20 μM etoposide for 24 h. GH, red; yH2AX, green; phalloidin, gray; DAPI, blue. A bright green nucleus indicates apoptosis. Scale bar, 20 um. Control, untreated cells.
(E)Western blot of GH in the culture medium of ANCC and organoids treated with 20 or 5 uM etoposide, respectively. The medium was collected from heat 8 and 24 h and from organoids at 4-48 h after treatment. Ponceau was used as a loading control. Representative blots from at least 3 independent experiments are shown.
were obtained by culturing organoids generated from iPSC lines 2 and 3 for 4 and 2 months, respectively (Figures S6A-S6D).
Furthermore, increased npGH in aged organoids was associated with attenuated DDR, with suppressed phosphorylation of both ATM and DNA-PKcs and lower levels of phosphorylated p53(Figures 6E and S5B). These results suggest that suppressed DDR activity leads to accumulated unrepaired DNA damage, as also evidenced by yH2AX induction (Figures 6E and S5B). After 2 months in culture, aged organoids infected with GH shRNA showed increased p53(Figures 6F and S7A) and decreased DNA damage measured by Comet assay (p<0.01)(Figure 6G), indicating a requirement for npGH in age-related DNA damage accumulation in this model.
GH signaling deficiency attenuates in vivo colon DNA damage in aging mice
To confirm our results obtained in aged organoids, we studied aged WT and GHR-7 mice in vivo. Colon DNA damage was significantly increased in old (24-month-old) versus young (3-month-old) WT mice(p<0.01), but, strikingly, was not increased in aged GHR-mice (Figures 7A and S7B), likely due to p53 in-duction. We also generated transgenic mice with colon-specific GHR excision (Car1-Cre/GHR"loxmox, GHRcolKO)(Figure S7D). Control mice were derived from the same breeding, but they did not harbor the Cre enzyme. Colon DNA damage was much reduced in 20-month-old male GHRcolKO mice with GHR excision compared to control mice, but not in the small intestine with intact GHR(Figure 7D). Thus, it appears that DNA is repaired more efficiently in mice devoid of GH signaling, likely due to the higher colon p53 expression we observed in both GHR-/-and in GHRcolKO animals(Figures 7B,7C, 7E, S7C, and S7E). These in vivo results buttress our hypothesis that npGH en-hances age-associated colon DNA damage accumulation.
DISCUSSION
We show here that npGH increases with age in human colon tissue and in 3D human intestinal organoids. We demonstrate several lines of evidence suggest that in aged human colon tissue,npGH is induced by DNA damage, as observed in human models, including epithelial non-tumorous cells, normal colon fibroblasts, organoids, and colon cancer tissue of patients undergoing DNA damaging therapies; we also show similar findings in vivo in the colons of mice with activated DDR.
Using 3D human intestinal organoids, we observed increased p16, senescence, and telomere shortening, all consistent with age-associated changes in human tissue (Baker et al.,2011; Liu et al.,2019; Lopez-Otin et al.,2013). Despite the limitations of the organoid model, our results support intestinal organoids as a faithful human recapitulation to study signaling mechanisms underlying age-associated colon changes(Hu et al.,2018).
We found that local npGH, acting in an autocrine/paracrine fashion, suppresses p53 and increases neighboring cell proliferation. Induced GH also suppresses DDR and DNA repair, further enhancing DNA damage accumulation. The results are also consistent with the observed effects on DNA damage accumulation within GH-secreting human pituitary tumors(Ben-Shlomo et al.,2020).
GH actions in normal colon tissue favor the development of a pro-proliferative milieu that may underlie age-related increased rates of colon polyps, exemplified by age-associated DNA dam-age and chromosomal instability as the drivers of colon cancer prevalence in patients older than 50 years (Aunan et al.,2017). The age-related increased DNA damage we show here is also consistent with reports that yH2AX increases linearly with age in normal colon specimens(Risques et al.,2008). Our observed marked upregulation of yH2AX in aging organoids is indicative of DNA damage accumulation, as yH2AX marks DNA damage sites to attract DNA repair proteins(Turinetto and Giachino,2015). These results may be seemingly inconsistent with the fact that GH induced in aging cells suppresses H2AX phosphorylation. However, we interpret these observations to show that GH de-creases DDR activity by decreasing phosphorylation of ATM, which, in turn, decreases (but does not completely abolish) the phosphorylation of downstream proteins including H2AX. When DDR is not appropriately activated, DNA repair is altered, but yH2AX still accumulates as it marks unrepaired DNA damage sites. Thus, yH2AX levels observed in aging human tissue and organoids reflect a net result of DDR activity and the amount of unrepaired DNA.
DNA damage may accumulate in aging tissue due to the loss of base excision repair, likely from the loss of p53 response to DNA damage (Cabelof et al.,2006; Simon et al., 2009, 2012). In our experiments, p53 declined in colon cells and organoids ex-pressing npGH, consistent with earlier findings of GH suppressing p53 (Chesnokova et al., 2016). By contrast, aged GHR-/-mice, which are resistant to cancer and have a longer lifespan (Basu et al.,2018), as well as colon-specific GHRcolKO mice exhibit an increased expression of colon p53, likely enhancing DNA repair. As GH suppresses p53 (Chesnokova et al., 2013), npGH induction may result in changes in the local microenvironment consistent with age-associated decreased p53(Feng et al., 2007; Goukassian et al.,2000). The GH promoter contains a p53 binding site (Chesnokova et al., 2013), and DNA damage-induced p53 activates GH expression (Chesnokova et al. 2013,2019a). Thus, our results show that in aged organoids, DNA damage accumulation induces npGH, which, in turn, down-regulates p53.
Importantly, as npGH is secreted locally from DNA-damaged cells, a paracrine action for secreted GH on neighboring cells could be operative. While co-culturing GH-expressing hNCF with the Colon Intestine-Chip, we observed increased DNA damage and proliferation and downregulated p53/p21 in chip-embedded epithelial cells exposed to the paracrine effects of fibroblast-derived up. These results suggest that local noninduced aging in human tissue alters the tissue micro-environment by suppressing tumor suppressor proteins and enhancing epithelial proliferation and DNA damage.
The results are consistent with observations that exogenous GH treatment increases proliferative capacity, colony formation, and metastases in DJ-1 KO mice (Chien et al., 2016), and with evidence that GH induction in human tumor cells is associated with the progression of several cancers(Perry et al.,2017); these comport with our results showing fewer colony formations and smaller colony size with GH suppression.
DNA damage repair pathways protect against chromosomal instability that drives cellular transformation (Negrini et al. 2010). For example, Tip60 activates ATM (Jackson and Bartek, 2009), and ATM, a central regulator of DDR, phosphorylates and stabilizes p53. Aging cells exhibit reduced ATM and p53 suppression, as well as DNA repair dysregulation with subsequent unrepaired DNA damage (Lan et al.,2019). Thus, in colon cells, DNA damage accumulates with age (Risques et al., 2008; Schu-macher et al., 2008), at least in part due to declining DDR efficiency (Jackson and Bartek, 2009), and suppressed p53 in response to y-irradiation in aging mice was attributed to age-related decline in p53-stabilizing ATM(Feng et al,2007).In our experiments, not induced in response to DNA damage also suppressed Tip60, which likely led to decreased DNA repair as evidenced by attenuated ATM and p53 phosphorylation, respectively. These results suggest that local npGHoverexpressionmay contribute to age-related dysregulated DDR and DNA repair. In aged organoids, GH induction attenuated DDR, while GH suppression activated DDR, as evidenced by decreased DNA damage. These results are supported by our earlier observations that blocking GH signaling in ANCC led to decreased DNA damage (Chesnokova et al.,2019a). Furthermore, we show that colon DNA damage does not accumulate in colon-targeted GHRcolKO mice with excised GHR, but it did accumulate in the small intestine, where GHRwas intact. These results, along with our demonstration that aged GHR-7-mice do not accumulate colon DNA damage, provide in vivo support for the hypothesis that local npGH induction with agemayrender cells susceptible to transformation and perhaps also contribute to cancer therapy resistance, as has been suggested (Basu and Kopchick,2019).
The results shown here also raise the possibility that GH effects may be mediated by insulin-like growth factor 1(IGF1). Unlike GH, IGF1 signaling activates DNA repair in non-tumorous and tumorous cells (Chesnokova and Melmed, 2020; Chitnis et al.,2014; Turney et al.,2012), and we have shown that GH suppression of p53 and induction of DNA dam-age occur independently of IGF1 in normal colon tissue (Ches-nokova et al.,2019a, 2019b). However, in cells and tissues in which GH activates IGF1, the latter growth factor may also signal in a cell-specific manner to counteract GH action on genome stability.
The findings suggest that npGH induced in aging colon tissue in response to accumulated DNA damage facilitates further DNA damage and appears to be an adverse determinant of DNA damage repair. Extrapolation of these findings provides a platform for several potential clinical applications. As DNA damage accumulation is a hallmark of age-related diseases, targeting GH signaling to block autocrine/paracrine no effects may prove useful for impeding age-related epithelial DNA damage and ultimately ameliorating the progression of age-related epithelial pathologies(Miman et al.,2016) Such an approach may also benefit cancer patients undergoing DNA-damaging therapies, in whom epithelial field changes engendered by autocrine/paracrine no action may damage normal neighboring tissue. In this regard, disrupting GH signaling with an approved GHR antagonist (List et al.,2011; Trainer et al, 2000)may confer clinical benefits. Importantly, human GH has been inappropriately promoted as an unapproved anti-ag-ing and strength-enhancing therapy(Giordano et al.,2008; Holt and Ho, 2019; Medeiros and Siegel Watkins,2018; Melmed, 2019). Given the deleterious paracrine effects of npGH that we report here, long-term inappropriate GH administration as an anti-aging elixir may elicit GHR signaling and risk the development of epithelial cell DNA damage, as well as the potential activation of occult proliferative lesions.
This article is extracted from Cell Reports 37, 110068, December 14, 2021, ª 2021 The Author(s). 1 This is an open-access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)






